These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3451587)

  • 1. [Effect of the treatment with encorton (Polfa) on the production of immunoglobulin G in the central nervous system of patients with multiple sclerosis].
    Ochudło S
    Wiad Lek; 1987 Dec; 40(23):1588-92. PubMed ID: 3451587
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].
    Ochudło S
    Wiad Lek; 1989 Dec; 41(23):1579-83. PubMed ID: 2669352
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of alternating treatment of multiple sclerosis with encorton and levamisole on IgG synthesis within the cerebrospinal fluid spaces].
    Wender M; Michałowska G; Tokarz-Kupczyk E
    Neurol Neurochir Pol; 1988; 22(2):103-7. PubMed ID: 3405385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of increased immunoglobulin G levels in the cerebrospinal fluid of patients with multiple sclerosis].
    Out TA; van der Helm HJ
    Ned Tijdschr Geneeskd; 1984 Sep; 128(35):1666-8. PubMed ID: 6483038
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].
    Tourtellotte WW
    Rev Neurol (Paris); 1972 Nov; 127(5):497-504. PubMed ID: 4588993
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of the synthesis of immunoglobulin G within the central nervous system.
    Whitaker JN
    Ann Neurol; 1985 Jan; 17(1):11-2. PubMed ID: 3985579
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin abnormalities in multiple sclerosis.
    Link H
    Ann Clin Res; 1973 Oct; 5(5):330-6. PubMed ID: 4209372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
    Hommes OR
    Ned Tijdschr Geneeskd; 1976 Mar; 120(10):424-30. PubMed ID: 765862
    [No Abstract]   [Full Text] [Related]  

  • 9. [IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
    Safár J; Vymazal J; Tichý J; Růzicková V
    Cas Lek Cesk; 1985 Sep; 124(36):1131-6. PubMed ID: 4028102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunoglobulin G synthesizing lymphocytes in the cerebrospinal fluid in multiple sclerosis and non-inflammatory diseases of the nervous system].
    Schädlich HJ; Bliersbach Y; Felgenhauer K; Schifferdecker M
    J Clin Chem Clin Biochem; 1984 Jul; 22(7):483-7. PubMed ID: 6481312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of prednisolone on the immunoglobulin content of the blood in patients with disseminated sclerosis].
    Iarosh AA; Prokopiv MM; Zhovnir IK; Kanevskaia SA
    Vrach Delo; 1990 Aug; (8):70-2. PubMed ID: 2256298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Function of the hemato-encephelic barrier and IgG synthesis in the central nervous system in multiple sclerosis and other neurologic disorders].
    Safár J; Vymazal J; Tichý J
    Cesk Neurol Neurochir; 1986 Nov; 49(6):382-9. PubMed ID: 3802248
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis onset during etanercept treatment.
    Gomez-Gallego M; Meca-Lallana J; Fernandez-Barreiro A
    Eur Neurol; 2008; 59(1-2):91-3. PubMed ID: 17934280
    [No Abstract]   [Full Text] [Related]  

  • 15. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis: an overview, with some observations on the spinal fluid protein.
    Darnell D; Abrams BM; Moroney J
    J Am Osteopath Assoc; 1974 Feb; 73(6):450-4. PubMed ID: 4360489
    [No Abstract]   [Full Text] [Related]  

  • 17. [IGG index or oligoclonal bands in the diagnosis of disseminated sclerosis].
    Sellebjerg F; Frederiksen JL
    Ugeskr Laeger; 1993 Feb; 155(8):558-60. PubMed ID: 8451791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sensitivity and efficiency of intrathecal IgG secretion in multiple sclerosis. Comparison of several indices and formulas using pre-established values of specificity].
    Cordero M; Viñuela F; Angulo S; Martínez-Parra C; Izquierdo G
    Neurologia; 1997; 12(7):277-80. PubMed ID: 9432195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid.
    Link H; Zettervall O
    Clin Exp Immunol; 1970 Mar; 6(3):435-8. PubMed ID: 4986119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.